No Data
TD Cowen Maintains Stifel Financial(SF.US) With Buy Rating, Maintains Target Price $94
TD Cowen analyst William Katz maintains $Stifel Financial(SF.US)$ with a buy rating, and maintains the target price at $94.According to TipRanks data, the analyst has a success rate of 61.4% and a tot
Stifel Client Assets Rise 3% in May, Driven by Recruiting, Market Gains
Express News | Stifel Reports May 2024 Operating Data
Investing in Stifel Financial (NYSE:SF) Five Years Ago Would Have Delivered You a 122% Gain
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. One great example is
MaaT Pharma Announces Initiation of Coverage of Its Stock by Stifel With a Buy Rating and a Target Price of EUR 16
LYON, France--(BUSINESS WIRE)--$MAAT--Regulatory News:MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Thera
Micron Stock Is on Fire. Analysts Say There's More Room for Gains.
Raymond James analyst Srini Pajjuri increased his price target for the chip stock to $160 from $130.